Of note, in one recent study a significant positive correlation was found between FLT3-ITD and ABCG2 overexpression, and DFS was shortest in patients with AML with both FLT3-ITD and ABCG2 overexpression [34]. The gene discussed is ABCG2; the disease is acute myeloid leukemia.